Disclosed are novel compounds which inhibit RSK, methods of making such compounds and pharmaceutical compositions comprising such compounds. Also disclosed are methods of treating RSK2 regulated disorders using compounds of the invention.
Disclosed are novel compounds which inhibit RSK, methods of making such compounds and pharmaceutical compositions comprising such compounds. Also disclosed are methods of treating RSK2 regulated disorders using compounds of the invention.
Incubations of the fungus Mortierella isabellina NRRL 1757 with -3-oxo-3-phenylpropanamide, 3-oxobutanamide and with some of their N-alkyl derivatives afford the corresponding (S)-3-hydroxyamides, usually in high chemical yields and enantiomeric excesses. (C) 1997 Elsevier Science Ltd.
Enantioselective hydrogenation of β-keto esters catalyzed by P-chiral bis(dialkylphosphino)ethanes-Ru(II)
Asymmetric hydrogenation of keto esters using a BisP*-RuBr2, catalyst is reported. High enantioselectivities up to 98% were achieved in the hydrogenation of beta-keto esters. (C) 1999 Elsevier Science Ltd. All rights reserved.